Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2022-08-16 08:22 am Purchase | 2022-08-15 | 13D | FORTE BIOSCIENCES FBRX | BML Investment Partners L.P. | 58,455 7.200% | 4,759 (+8.86%) | Filing History |
| 2022-07-07 08:22 am Purchase | 2022-07-06 | 13D | FORTE BIOSCIENCES FBRX | BML Investment Partners L.P. | 53,696 9.100% | 896 (+1.70%) | Filing History |
| 2022-06-07 4:41 pm Purchase | 2022-06-01 | 13G | TERNS PHARMACEUTICALS INC TERN | BML Investment Partners L.P. | 1,764,274 7.000% | 1,764,274 (New Position) | Filing History |
| 2022-05-24 12:19 pm Purchase | 2022-05-24 | 13D | FORTE BIOSCIENCES FBRX | BML Investment Partners L.P. | 52,800 8.940% | 17,250 (+48.52%) | Filing History |
| 2022-05-10 12:40 pm Purchase | 2022-05-04 | 13G | ADVERUM BIOTECHNOLOGIES INC CO ADVM | BML Investment Partners L.P. | 517,550 5.200% | 517,550 (New Position) | Filing History |
| 2022-05-04 11:25 am Purchase | 2022-04-26 | 13G | CLIMB BIO, INC. CLYM | BML Investment Partners L.P. | 1,739,378 6.500% | 1,739,378 (New Position) | Filing History |
| 2022-05-04 11:00 am Purchase | 2022-04-26 | 13G | FORTE BIOSCIENCES FBRX | BML Investment Partners L.P. | 35,550 6.000% | 35,550 (New Position) | Filing History |
| 2022-05-02 4:33 pm Purchase | 2022-04-28 | 13G | RETRACTABLE TECHNOLOGIES INC. RVP | BML Investment Partners L.P. | 3,737,500 11.300% | 929,500 (+33.10%) | Filing History |
| 2022-04-25 11:59 am Purchase | 2022-04-21 | 13G | IMARA INC IMRA | BML Investment Partners L.P. | 3,180,000 12.100% | 1,547,667 (+94.81%) | Filing History |
| 2022-04-14 10:13 am Purchase | 2022-04-06 | 13G | IMARA INC IMRA | BML Investment Partners L.P. | 1,632,333 6.200% | 1,632,333 (New Position) | Filing History |
| 2022-04-13 4:11 pm Purchase | 2022-04-11 | 13G | GEMINI THERAPEUTICS INC GMTX | BML Investment Partners L.P. | 527,000 12.200% | 294,030 (+126.21%) | Filing History |
| 2022-03-10 2:01 pm Unchanged | 2022-03-04 | 13G | GEMINI THERAPEUTICS INC GMTX | BML Investment Partners L.P. | 232,970 5.400% | 0 (Unchanged) | Filing History |
| 2022-03-10 1:16 pm Purchase | 2022-03-04 | 13G | GEMINI THERAPEUTICS INC GMTX | BML Investment Partners L.P. | 232,970 5.400% | 232,970 (New Position) | Filing History |
| 2022-03-03 1:30 pm Purchase | 2022-02-23 | 13G | ASTROTECH CORP COM ASTC | BML Investment Partners L.P. | 86,244 5.200% | 86,244 (New Position) | Filing History |
| 2022-02-17 8:27 pm Purchase | 2022-02-11 | 13G | METACRINE INC MTCR | BML Investment Partners L.P. | 1,600,000 5.900% | 1,600,000 (New Position) | Filing History |
| 2022-01-28 3:36 pm Unchanged | 2022-01-19 | 13G | ODONATE, INC. ODTC | BML Investment Partners L.P. | 0 7.400% | 0 (Unchanged) | Filing History |
| 2022-01-28 3:29 pm Unchanged | 2022-01-28 | 13G | ODONATE, INC. ODTC | BML Investment Partners L.P. | 0 7.400% | 0 (Unchanged) | Filing History |
| 2022-01-27 3:53 pm Purchase | 2022-01-24 | 13G | ARCA BIOPHARMA INC PAR $.0 ABIO | BML Investment Partners L.P. | 63,488 5.300% | 63,488 (New Position) | Filing History |
| 2022-01-27 2:58 pm Sale | 2022-01-27 | 13G | TILLYS INC TLYS | BML Investment Partners L.P. | 737,500 3.100% | -612,500 (-45.37%) | Filing History |
| 2022-01-27 2:51 pm Sale | 2022-01-27 | 13G | ACELRX PHARMACEUTICALS INC ACRX | BML Investment Partners L.P. | 0 0.000% | -297,800 (Position Closed) | Filing History |